We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Handheld Immunoanalyzer Performs Laboratory Tests near Patient without Sacrificing Sensitivity and Precision

By LabMedica International staff writers
Posted on 22 Mar 2023
Print article
Image: The Profile System is a portable and fully automated immunodiagnostic device (Photo courtesy of Proxim Diagnostics)
Image: The Profile System is a portable and fully automated immunodiagnostic device (Photo courtesy of Proxim Diagnostics)

Near Patient Testing (NPT), also known as Point of Care Testing (POCT), is a rapidly growing area within the field of In vitro diagnostics (IVDs). NPT is now recognized for its key role in making services more patient-centered by bringing diagnostic testing closer to the patient. This shift has the potential to significantly transform the way healthcare services are delivered to patients. By enabling timely diagnosis at the bedside, in community settings, or even in general practice, the delivery of care can be made much more efficient, allowing patients to receive the right diagnosis and treatment in a timely and convenient manner. Now, a handheld portable immunoanalyzer with the sensitivity and precision of centralized laboratory equipment is currently being developed in a form factor suitable for low-cost, point-of-care testing anywhere in the world.

Proxim Diagnostics Corp. (Santa Clara, CA, USA) is developing the Profile System, a portable and fully automated immunodiagnostic device that can run several types of multiplexed assays using disposable cartridges. The system performs critical laboratory tests near the patient using whole blood without sacrificing sensitivity and precision to deliver the most critical information to the doctors right when they need it. The Profile System is battery operated, and offers a touch-screen display interface, along with wireless, Ethernet, and USB connectivity.

The handheld device is expected to enhance the ability of clinicians to perform rapid, high-quality testing at the point of care, such as in emergency rooms, intensive care units, nursing homes, community/remote clinics and in-home care, as well as in disaster relief and defense situations. The system is currently available for research use only. Proxim is also developing several immunoassays for sepsis, cardiology, and infectious diseases that can match the sensitivity and precision of tests that are run on larger, centralized laboratory equipment.

Related Links:
Proxim Diagnostics Corp.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.